for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Cytocom Reports Successful Completion of FDA Meeting Regarding Trial Of CYTO-201 In COVID-19

June 29 (Reuters) -

* CYTOCOM, INC. ANNOUNCES SUCCESSFUL COMPLETION OF TYPE-B PRE-IND MEETING WITH FDA REGARDING PROPOSED PHASE 2 CLINICAL TRIAL OF CYTO-201 IN COVID-19 PATIENTS Source text for Eikon:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up